We have a mission!

PulseCath® is focused on developing ground-breaking technologies designed to assist the life sustaining pumping functions of the failing heart.

SEE OUR

Facts & Figures

  • Registrations

    > 45 countries approved registrations

  • Cases

    > 100 shared cases on LinkedIn; > 200 reported cases

  • > 1.000 iVAC 2L sold

    > 35 distributor agreements

  • Hospitals

    > 35 hospitals use iVAC 2L on a regular base; > 7 Centers of Excellence.

  • Patients

    > 400 patients world wide treated by iVAC 2L

  • Clinical evidence

    > 30 publications

  • Indication

    The iVAC 2L is intended for use in patients with impaired left ventricular function which require left ventricular mechanical circulatory support for up to 24 hours

  • DISTRIBUTORS

    All over the world

    Grow with us!Take a look at our list of distributors

    MEET OUR

    Medical advisors

    Clinical programme supported by leading cardiologists

    THIS IS

    Our team

    iVAC 2L Procedure Steps

    iVAC 2L Setup

    iVAC 2L Trouble Shooting

    iVAC 2L Clinical Effect

    Complete webinar

    Home

    Session